| |
|
|
|
Oxford Global, Central London
18-19 May 2016
Oxford Global Conferences are proud to announce the 2nd Annual Formulation & Drug Delivery Congress, taking place on 18 – 19 May 2016 in London, UK. Our highly anticipated event provides a unique opportunity for over 150 formulation and drug delivery leaders to network and engage in scientific discussions about the most exciting areas of research that will shape the future landscape of the industry. Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss over 40 presentations and case studies focused on the key issues in biologics and small molecule drug formulation and delivery
The Congress will cover 4 interactive streams:
- Biologics Formulation
- Small Molecule Drugs Formulation
- Biologics Drug Delivery
- Small Molecule Drugs Delivery
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
2016 Speakers Include:
- Joel Richard, Senior Vice President, Peptides – Head of CMCS Dreux Site, Ipsen
- Justin M Wright, Vice President, Drug Delivery Innovation, Eli Lilly and Company
- Anand Subramony, Vice President, Drug Delivery & Device Development, MedImmune
- Allen C. Templeton, Associate Vice President, Formulation Sciences, Merck
- Abla Creasey, Senior Scientific Director, Janssen
- Agneta Walhagen, Executive Director, Leo Pharma
- René Holm, Senior Director, Pharmaceutical Science, H. Lundbeck A/S
- Anthony Leone, Director, Preformulation, Merck
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
For further information regarding registration and prices, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248455
|
|
|
E-mail:
|
|
g.alonso@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|